{"id":371669,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2026-02-26] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:04:37.684000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2026-02-26.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2026-02-26] February 26, 2026 Our file number: 26-100917-526 The purpose of this Notice of Amendment is to announce the addition of nemolizumab, nipocalimab, olezarsen sodium, pegunigalsidase alfa, plozasiran,…","rawSnapshotUrl":"/api/snapshots/raw/371669","browseUrl":"https://replay.healtharchive.ca/job-6/20260411150437/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2026-02-26.html#ha_snapshot=371669","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}